The cost of launching a drug on to the market has recently been estimated at $2.6 billion. On average it is estimated that between 5,000 and 10,000 potential drug molecules are investigated to produce one approved therapy. The huge cost of drug discovery has forced new paths for R&D, with CROs and outsourcing becoming increasingly competitive alternative models to traditional pharmaceutical R&D. The potential profitability of drugs is also influenced by their development time, as it takes on average 10 years to move a molecule from the discovery stage to an approved drug on the shelves, and the twenty year patent exclusivity period begins when human trials are underway.
Fortunately, development bottlenecks can be opened up through the adoption of automated workflow solutions into your laboratory. Utilizing a range of interconnected automated platforms, the workflow can be designed to significantly cut the time taken to produce a target molecule of sufficient purity. The Biotage automated workflow solution is based around three technologies that interconnect to reduce the overall time to target molecule:
In combination, these technologies vastly speed the time taken to go from the concept of a target molecule to the final product.
The Biotage automated workflow solution delivers target molecules in on average a fifth of the time of traditional chemistry. The Biotage automated workflow is also built around greener chemistry, significantly reducing the consumption of chemicals. As a result, adoption of the workflow produces a laboratory with a significantly improved environmental profile in terms of carbon footprint, with accompanying reduction in purchasing, storage and disposal costs. A single automated workflow with one provider means that downtime is reduced, as service and preventative maintenance can be scheduled across the entire workflow. Utilizing the Biotage automated workflow allows the laboratory to become more flexible to incoming projects and changes in demands on resource. This ensures that the laboratory remains competitive with other recipients of R&D funding.
Update on Biotage’s COVID-19 Response Plan
Smarter Sample Preparation for Environmental Challenges
How does Biotage Act in the Corona Virus Situation?
Sample Preparation Techniques for Synthetic Benzodiazepines
Good Laboratory Practices Software Upgrade for Biotage® Extrahera™